Private Capital Group’s Sage Therapeutics SAGE Stock Holding History

Private Capital Group’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$7K	Hold	230	–	–	0.01%	1155
2022 Q1	$8K	Buy	230 +202	+721%	+$7.59K	﹤0.01%	1358
2021 Q4	$1K	Sell	28 -85	-75%	-$3.56K	﹤0.01%	1983
2021 Q3	$5K	Sell	113 -211	-65%	-$9.68K	﹤0.01%	1598
2021 Q2	$18K	Sell	324 -207	-39%	-$14.6K	﹤0.01%	1148
2021 Q1	$40K	Buy	531 +373	+236%	+$30.6K	0.01%	746
2020 Q4	$14K	Buy	158 +3	+2%	+$221	﹤0.01%	1314
2020 Q3	$9K	Buy	155 +78	+101%	+$3.95K	﹤0.01%	1358
2020 Q2	$3K	Sell	77 -37	-32%	-$1.34K	﹤0.01%	1626
2020 Q1	$3K	Buy	114 +94	+470%	+$5.44K	﹤0.01%	1618
2019 Q4	$1K	Sell	20 -95	-83%	-$11.7K	﹤0.01%	1849
2019 Q3	$16K	Buy	+115	New	+$19.2K	﹤0.01%	1292

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Private Capital Group's SAGE Position: Q2 2022 in Review

Private Capital Group held its Sage Therapeutics (SAGE) position steady in Q2 2022 at 230 shares worth $7K. The position accounts for 0.01% of the portfolio, ranked #1155.

Private Capital Group first reported a position in SAGE in Q3 2019 and has held it in 12 quarters since. The position peaked at $40K in Q1 2021. 210 funds tracked by Wall St. Rank hold SAGE as of Q2 2022.

Private Capital Group held 230 shares of Sage Therapeutics worth $7K as of Q2 2022.
Private Capital Group left its Sage Therapeutics share count unchanged in Q2 2022.
Sage Therapeutics made up 0.01% of Private Capital Group's portfolio in Q2 2022, its #1155 holding.
Private Capital Group first reported a position in Sage Therapeutics in Q3 2019 and has held it in 12 quarters since.
Private Capital Group's Sage Therapeutics position peaked at $40K in Q1 2021.
210 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.